Somatic effects in nuclear medicine and radiology

Applied Radiation and Isotopes

Volumn 50, Issue 1, 1999, Pages 63-72

  Overbeek, F J ^a   Pauwels, E K J ^a   Bloem, J L ^a   Camps, J A J ^a   Geleijns, J ^a,b   Broerse, J J ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC RADIOGRAPHY; EPIDEMIOLOGY; HEALTH RISKS; NUCLEAR MEDICINE; ONCOLOGY; RADIOLOGY;

RADIATION CARCINOGENESIS; SOMATIC RADIATION EFFECTS;

BIOLOGICAL RADIATION EFFECTS;

(3 IODOBENZYL)GUANIDINE; COBALT 60; GALLIUM CITRATE GA 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IODINE 123; IODINE 131; MERTIATIDE TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETATE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; GAMMA IRRADIATION; HUMAN; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIODIAGNOSIS;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS, RADIATION-INDUCED; NETHERLANDS; RADIATION DOSAGE; RADIOGRAPHY; RADIONUCLIDE IMAGING; RISK FACTORS;

EID: 0032957979     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(98)00032-3     Document Type: Article

References (48)

1. Beekhuis H. Population radiation absorbed dose from nuclear medicine procedures in The Netherlands. Health Phys. 54:1988;287-291.
2. Beentjes L. B., Timmermans C. W. Age and sex specific population doses (SED (somatic effective dose equivalent) and GSD (genetically significant dose equivalent) due to nuclear medicine procedures in The Netherlands. Int. Nucl. Med. Biol. 17:1990;261-268.
3. BEIR, 1980. Report. US National Research Council. National Academy Press
4. Bishop J. M. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:1983;301-354.
5. Boice J. D. Jr., Blettner M., Kleinerman R. A., Stovall M., Moloney W. C., Engholm G., Austin D. F., Bosch A., Cookfair D. L., Krementz E. T.et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl. Cancer Inst. 79:1987;1295-1311.
6. Boice J. D. Jr., Engholm G., Kleinerman R. A., Blettner M., Stovall M., Lisco H., Moloney W. C., Austin D. F., Bosch A., Cookfair D. L.et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res. 116:1988;3-55.
7. Brown W. M., Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br. Med. J. 5474:1965;1327-1332.
8. Clarke R. H., Southwood T. R. Risks from ionising radiation. Nature. 338:1989;197-198.
9. Darby S. C., Doll R., Gill S. K., Smith P. G. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer. 55:1987;179-190.
10. Friere-Maia A., Friere-Maia D. V. Mortality rates in a Brazilian area of high background radiation. Preliminary analysis based on official records (abstract). Nucl. Sci. 22:1968;38453.
11. Frigerio, N. A., Stowe, R. S., 1976. Carcinogenic and Genetic Hazard from Background Radiation, in Biological and Environmental Effects of Low-Level Radiation, pp. 385-393. International Atomic Energy Agency, Vienna
12. Fritz Niggli H. 100 years of radiobiology: implications for biomedicine and future perspectives. Experientia. 51:1995;652-664.
13. Geleijns, J., 1995. Patient Dosimetry in Diagnostic Radiology: Chest Examinations and Computed Tomography. Thesis, Leiden University Medical Centre, The Netherlands
14. Hall E. J., Freyer G. A. The molecular biology of radiation carcinogenesis. Basic Life Sci. 58:1991;3-19.
15. 60Co gamma-rays Cancer Res. 40:1980;3328-3332.
16. Huda W., Gordon K. Nuclear medicine staff and patient doses in Manitoba (1981-1985). Health Phys. 56:1989;277-285.
17. ICRP, 1977. Recommendation of the ICRP, ICRP Publication 26
18. ICRP, 1985. Principles Involved in Developing an Index of Harm, ICRP Publication 27
19. ICRP, 1991a. The Biological Basis for Dose Limitation in the Skin. ICRP Publication 59. International Commission on Radiological Protection
20. ICRP, 1991b. Recommendations of the International Commission on Radiological Protection, ICRP Publication 60. International Commission on Radiological Protection
21. ICRP, 1991c. Radiological Protection in Biomedical Research, Annals of the ICRP publication 62. International Commission on Radiological Protection
22. Kicken, P. J. H., 1996. Radiation dosimetry in vascular radiology: Organ and effective dose to patients and staff. Thesis, University Hospital Maastricht, The Netherlands
23. Land C. E. Estimating cancer risks from low doses of ionising radiation. Science. 209:1980;1197-1203.
24. Land C. E., Boice J. D. Jr., Shore R. E., Norman J. E., Tokunaga M. Breast cancer risk from low-dose exposures to ionising radiation: results of parallel analysis of three exposed populations of women. J. Natl. Cancer Inst. 65:1980;353-376.
25. Mettler F. A. Jr., Christie J. H., Williams A. G. Jr., Moseley R. D. Jr., Kelsey C. A. Population characteristics and absorbed dose to the population from nuclear medicine: United States-1982. Health Phys. 50:1986;619-628.
26. Mills, W. A., Youmans, H. D., 1968. Population exposures from natural background radiation in Kerala, India (abstract). Health Phys. 14, 188
27. Mountford P. J. Risk assessment of the nuclear medicine patient. Br. J. Radiol. 70:1997;671-684.
28. NIH, 1985. Report of the National Institutes of health ad hoc Working Group to develop Radioepidemiological Tables. US Department of Health and Human Services
29. Overbeek F., Pauwels E. K. J., Broerse J. J. Carcinogenic risk in diagnostic nuclear medicine: biological and epidemiological considerations. Eur. J. Nucl. Med. 21:1994;997-1012.
30. Pauwels E. K. J. Of Mozart and MIBI. Eur. J. Nucl. Med. 18:1991;445-446.
31. Pollycove M. The issue of the decade: hormesis. Eur. J. Nucl. Med. 22:1995;399-401.
32. Report on a workshop to examine methods to arrive at risk estimates for radiation- induced cancer in the human based on laboratory data (1993) Radiat. Res. 135, 434-437
33. Roth J., Schweizer P., Guckel C. Grundlagen des strahlenschutzes (Basis of radiation protection). Schweiz Med. Wochenschr. 126:1996;1157-1171.
34. Shimizu, Y., Kato, H., Schull, W. J., Preston, D., Fujita, S. and Pierce, D., 1987. Life span study report 11, part 1Comparison of risk coefficients for risk specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Radiation Effects Research Foundation
35. Shimizu, Y., Kato, H. and Schull, W. J. (1988) Life span study report 11, part 2Cancer mortality in the years 1950-1985 based on the recently revised doses (DS86). Radiation Effects Research Foundation
36. Shope T. B. Radiation-induced skin injuries from fluoroscopy. Radiographics. 16:1996;1195-1199.
37. Smith, P. G., Doll, R., 1978. Age and time dependent changes in the rates of radiation induced cancers in patients with ankylosing spondylitis following a single course of X-ray treatment. Atomic Energy Agency Symposium; March 1978, paper No. IAES-SM-224/711.C
38. UNSCEAR, 1977. Sources and effects of ionising radiation (UNE 77 IX 1) Report to the General Assembly
39. UNSCEAR, 1982. Ionising Radiation: Sources and Biological Effects. United Nations Scientific Committee on the Effects of Atomic Radiation
40. UNSCEAR, 1986. Genetic and somatic effects of ionising radiation. Unscear 1986 Report to the General Assembly, with annexes. United Nations Scientific Committee on the Effects of Atomic Radiation
41. UNSCEAR, 1988. Sources, Effects and Risks of Ionising Radiation of Ionising Radiation
42. UNSCEAR, 1988. Report to the General Assembly, with annexes. United Nations Scientific Committee on the Effects of Atomic Radiation
43. Upton, A., 1986. Radiation Carcinogenesis. Elsevier, New York
44. Upton A. C. Cancer induction and non-stochastic effects. Br. J. Radiol. 60:1987;1-16.
45. Van Wyngaarden K. E., Pauwels E. K. J. Hormesis: are low doses of ionising radiation harmful or beneficial? Eur. J. Nucl. Med. 22:1995;481-486.
46. Wagner L. K., Eifel P. J., Geise R. A. Potential biological effects following high X-ray dose interventional procedures. J. Vasc. Int. Radiol. 5:1994;71-84.
47. Wakabayashi T., Kato H., Ikeda T., Schull W. J. Studies of the mortality of A-bomb survivors, report 7. Part III. Incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki. Radiat. Res. 93:1983;112-146.
48. Zoetelief, J., Beentjes, L. B., Broerse, J. J., Julius, H. W., Busemann-Sokole, E., 1995. Quality assurance and population dose in diagnostic radiology and imaging: State of the art in the Netherlands. Radiation Protection Dosimetry 57, 59-64. nuclear medicine